SEATTLE, July 22, 2021, (MEDGADGET) — Global Sulfachloropyridazine Sodium Market Analysis
Overview
The sulfonamide antibiotic sulfachloropyridazine sodium is used to examine dynamics and reactive routes. It is also used to treat pediatric children with acute UTIs (urinary tract infections). By blocking the enzyme dihydropteroate synthase and bacterial PABA (Para-Amino Benzoic Acid), sulfachloropyridazine sodium prevents the formation of dihydrofolic acid, which is necessary for bacterial development. The substance Sulfachloropyridazine sodium powder cures pasteurellosis in a variety of animals and is widely used in livestock farming.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2263
Drivers
The global sulfachloropyridazine sodium market is projected to increase due to an increase in the usage of antibiotics in cattle to treat certain diseases. As per a study published in the journal Science in 2017, cows, pigs, and chickens get about 80% of all antibiotics used in the U.S. to keep them healthy and promote their development and growth.
Sulfonamides are also one of the most popular antifungal drugs used in veterinary medicine, as per the Louisiana Department of Health in the United States, due to their low cost and considerably better efficacy against several common bacterial infections, which is enhancing the growth of the global sulfachloropyridazine sodium market.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2263
Restraint
Bacterial infections have developed resistance to the sulfonamide family of antibiotics over time, either as a result of changes in pre-existing DNA or through the acquisition of ARGs (Antibiotic Resistance Genes), which is projected to stifle growth of the global sulfachloropyridazine sodium market. As per a paper published in the journal Microbiome in 2017, the use of sulfonamide antibiotics for animals is confined to topical usage exclusively. Nearly 38 tons of sulfonamides were legally supplied to the U.S. in 2015 to boost the resistance power of food-producing animals. As a result, the emergence of sulfonamide resistance would have hampered the global sulfachloropyridazine sodium market.
Regional Insights
Due to the high frequency of Urinary Tract Infections (UTIs) in the U.S., the North America region is forecast to obtain the largest proportion of the global sulfachloropyridazine sodium market. As per the American Urological Association, over 1 million catheter-associated UTIs are reported each year in the U.S., and up to 40% of hospital gram negative bacteremias are caused by UTIs.
Due to the participation of key companies in producing antibiotics only for veterinary uses, the Asia Pacific region is projected to see considerable expansion in the global sulfachloropyridazine sodium market. Weifang Premier Animal Pharmaceutical Industries Co., Ltd, a China-based corporation that is also active in animal husbandry, is one of the companies. Sulfachloropyridazine sodium soluble powder is one of their important products in China, and it aids in animal health.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2263
Competitive Landscape
Major companies contributing in the global sulfachloropyridazine sodium market are AK Scientific Inc., UBM, Santa Cruz Biotechnology, Inc., Zhengzhou Fuyuan Chemical Industry Corporation Limited, Sigma-Aldrich, Inc., Ofichem Group, Shanghai Danfan Network Science&Technology Corporation Limited, Quimica Alkano, Hefei TNJ Chemical Industry Corporation, and SuZhou Wugan Pharmaceutical Corporation.
Table of Content
Global Sulfachloropyridazine Sodium Market Research Report
Section 1: Global Sulfachloropyridazine Sodium Industry Overview
Section 2: Global Economic Impact on Sulfachloropyridazine Sodium Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Sulfachloropyridazine Sodium Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Sulfachloropyridazine Sodium Market Forecast
Have a Look at Related Research Insights:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837